The pharmacokinetics of anthocyanins and their metabolites in humans

R M de Ferrars, C Czank, Q Zhang, N P Botting, P A Kroon, A Cassidy, C D Kay, R M de Ferrars, C Czank, Q Zhang, N P Botting, P A Kroon, A Cassidy, C D Kay

Abstract

Background and purpose: Anthocyanins are phytochemicals with reported vasoactive bioactivity. However, given their instability at neutral pH, they are presumed to undergo significant degradation and subsequent biotransformation. The aim of the present study was to establish the pharmacokinetics of the metabolites of cyanidin-3-glucoside (C3G), a widely consumed dietary phytochemical with potential cardioprotective properties.

Experimental approach: A 500 mg oral bolus dose of 6,8,10,3',5'-(13)C5-C3G was fed to eight healthy male participants, followed by a 48 h collection (0, 0.5, 1, 2, 4, 6, 24, 48 h) of blood, urine and faecal samples. Samples were analysed by HPLC-ESI-MS/MS with elimination kinetics established using non-compartmental pharmacokinetic modelling.

Key results: Seventeen (13)C-labelled compounds were identified in the serum, including (13)C5-C3G, its degradation products, protocatechuic acid (PCA) and phloroglucinaldehyde (PGA), 13 metabolites of PCA and 1 metabolite derived from PGA. The maximal concentrations of the phenolic metabolites (Cmax ) ranged from 10 to 2000 nM, between 2 and 30 h (tmax) post-consumption, with half-lives of elimination observed between 0.5 and 96 h. The major phenolic metabolites identified were hippuric acid and ferulic acid, which peaked in the serum at approximately 16 and 8 h respectively.

Conclusions and implications: Anthocyanins are metabolized to a structurally diverse range of metabolites that exhibit dynamic kinetic profiles. Understanding the elimination kinetics of these metabolites is key to the design of future studies examining their utility in dietary interventions or as therapeutics for disease risk reduction.

Keywords: anthocyanins; ferulic acid; hippuric acid; metabolites; vanillic acid.

© 2014 The Authors. British Journal of Pharmacology published by John Wiley & Sons Ltd on behalf of The British Pharmacological Society.

Figures

Figure 1
Figure 1
Structure of 6,8,10,3′,5′-13C5-cyanidin-3-glucoside.
Figure 2
Figure 2
Serum pharmacokinetic profiles of (A) C3G, (B) PCA and its metabolites and (C) methylated PCA and its metabolites, in humans after the consumption of 500 mg 13C5-C3G in eight healthy male participants. All data are mean ± SEM. C3G, cyanidin-3-glucoside; GlcA, glucuronide; M34dhbz, methyl-3,4-dihydroxybenzoate; PCA, protocatechuic acid; VA, vanillic acid.
Figure 3
Figure 3
Serum pharmacokinetic profiles of (A) benzoic acid metabolites, (B) propenoic acid metabolites, and (C) A-ring-derived and aldehyde metabolites of cyanidin-3-glucoside in humans after the consumption of 500 mg 13C5-C3G in eight healthy male participants. All data are mean ± SEM. BA, benzoic acid; BAL, benzaldehyde; GlcA, glucuronide; PGA, phloroglucinaldehyde.
Figure 4
Figure 4
Urinary elimination profiles of (A) C3G and its metabolites, (B) PCA and its metabolites, and (C) methylated PCA and its metabolites in humans after the consumption of 500 mg 13C5-C3G in eight healthy male participants. All data are mean ± SEM. C3G, cyanidin-3-glucoside; Cy, cyanidin; GlcA, glucuronide; M34dhbz, methyl-3,4-dihydroxybenzoate; Me, methylated; P3G, peonidin-3-glucoside; PCA, protocatechuic acid; VA, vanillic acid.
Figure 5
Figure 5
Urinary elimination profiles of (A) benzoic acid metabolites, (B) propenoic acid metabolites, and (C) A-ring-derived and aldehyde metabolites of cyanidin-3-glucoside in humans after the consumption of 500 mg 13C5-C3G in eight healthy male participants. All data are mean ± SEM. 4-HBAL, 4-hydroxybenzaldehyde; BA, benzoic acid; BAL, benzaldehyde; GlcA, glucuronide; PAA, phenylacetic acid; PGA, phloroglucinaldehyde.
Figure 6
Figure 6
Proposed pathway for the metabolism of cyanidin-3-glucoside in humans. *Conjugates represent unknown structural position. BA, benzoic acid; BAL, benzaldehyde; C3G, cyanidin-3-glucoside; Cy, cyanidin; GlcA, glucuronide; Me, methoxy; M34dhbz, methyl-3,4-dihydroxybenzoate; P3G, peonidin-3-glucoside; PAA, phenylacetic acid; PGA, phloroglucinaldehyde.

References

    1. Anupongsanugool E, Teekachunhatean S, Rojanasthien N, Pongsatha S, Sangdee C. Pharmacokinetics of isoflavones, daidzein and genistein, after ingestion of soy beverage compared with soy extract capsules in postmenopausal Thai women. BMC Pharmacol Toxicol. 2005;5:2.
    1. Azzini E, Bugianesi R, Romano F, Di Venere D, Miccadei S, Durazzo A, et al. Absorption and metabolism of bioactive molecules after oral consumption of cooked edible heads of Cynara scolymus L. (cultivar Violetto di Provenza) in human subjects: a pilot study. Br J Nutr. 2007;97:963–969.
    1. Bell DR, Gochenaur K. Direct vasoactive and vasoprotective properties of anthocyanin-rich extracts. J Appl Physiol. 2006;100:1164–1170.
    1. Cardona F, Andrés-Lacueva C, Tulipani S, Tinahones FJ, Queipo-Ortuño MI. Benefits of polyphenols on gut microbiota and implications in human health. J Nutr Biochem. 2013;24:1415–1422.
    1. Cassidy A, O'Reilly ÉJ, Kay CD, Sampson L, Franz M, Forman J, et al. Habitual intake of flavonoid subclasses and incident hypertension in adults. Am J Clin Nutr. 2011;93:338–347.
    1. Cassidy A, Mukamal KJ, Liu L, Franz M, Eliassen AH, Rimm EB. High anthocyanin intake is associated with a reduced risk of myocardial infarction in young and middle-aged women. Circulation. 2013;127:188–196.
    1. Czank C, Cassidy A, Zhang Q, Morrison DJ, Preston T, Kroon PA, et al. Human metabolism and elimination of the anthocyanin, cyanidin-3-glucoside: a 13C-tracer study. Am J Clin Nutr. 2013;97:995–1003.
    1. Das NP, Griffiths LA. Studies on flavonoid metabolism. Metabolism of (+)-[14C] catechin in the rat and guinea pig. Biochem J. 1969;115:831–836.
    1. Del Rio D, Borges G, Crozier A. Berry flavonoids and phenolics: bioavailability and evidence of protective effects. Br J Nutr. 2010;104(Suppl. 3):S67–S90.
    1. Erdman JW, Jr, Balentine D, Arab L, Beecher G, Dwyer JT, Folts J, et al. Flavonoids and heart health: proceedings of the ILSI North America Flavonoids Workshop, May 31-June 1, 2005, Washington, DC. J Nutr. 2007;137:718S–737S.
    1. de Ferrars RM, Cassidy A, Curtis P, Kay CD. Phenolic metabolites of anthocyanins following a dietary intervention study in postmenopausal women. Mol Nutr Food Res. 2014;58:490–502.
    1. Forester SC, Waterhouse AL. Identification of Cabernet Sauvignon anthocyanin gut microflora metabolites. J Agric Food Chem. 2008;56:9299–9304.
    1. Garcia-Alonso M, Minihane A-M, Rimbach G, Rivas-Gonzalo JC, de Pascual-Teresa S. Red wine anthocyanins are rapidly absorbed in humans and affect monocyte chemoattractant protein 1 levels and antioxidant capacity of plasma. J Nutr Biochem. 2009;20:521–529.
    1. Gonzalez-Barrio R, Edwards C, Crozier A. Colonic catabolism of ellagitannins, ellagic acid, and raspberry anthocyanins: in vivo and in vitro studies. Drug Metab Dispos. 2011;39:1680–1688.
    1. Ichiyanagi T, Rahman MM, Kashiwada Y, Ikeshiro Y, Shida Y, Hatano Y, et al. Absorption and metabolism of delphinidin 3-O-β-d-glucopyranoside in rats. Free Radic Biol Med. 2004;36:930–937.
    1. Kay CD, Mazza G, Holub BJ, Wang J. Anthocyanin metabolites in human urine and serum. Br J Nutr. 2004;91:933–942.
    1. Kay CD, Mazza G, Holub BJ. Anthocyanins exist in the circulation primarily as metabolites in adult men. J Nutr. 2005;135:2582–2588.
    1. Kay CD, Kroon PA, Cassidy A. The bioactivity of dietary anthocyanins is likely to be mediated by their degradation products. Mol Nutr Food Res. 2009;53(S1):92–101.
    1. Kim HJ, Tsoy I, Park JM, Chung JI, Shin SC, Chang KC. Anthocyanins from soybean seed coat inhibit the expression of TNF-α-induced genes associated with ischemia/reperfusion in endothelial cell by NF-κB-dependent pathway and reduce rat myocardial damages incurred by ischemia and reperfusion in vivo. FEBS Lett. 2006;580:1391–1397.
    1. Kim S-J, Kim M-C, Um J-Y, Hong S-H. The beneficial effect of vanillic acid on ulcerative colitis. Molecules. 2010;15:7208–7217.
    1. Kim SY, Moon K-A, Jo H-Y, Jeong S, Seon S-H, Jung E, et al. Anti-inflammatory effects of apocynin, an inhibitor of NADPH oxidase, in airway inflammation. Immunol Cell Biol. 2011;90:441–448.
    1. Manach C, Williamson G, Morand C, Scalbert A, Rémésy C. Bioavailability and bioefficacy of polyphenols in humans. I. Review of 97 bioavailability studies. Am J Clin Nutr. 2005;81:230S–242S.
    1. McGhie TK, Walton MC. The bioavailability and absorption of anthocyanins: towards a better understanding. Mol Nutr Food Res. 2007;51:702–713.
    1. Min S-W, Ryu S-N, Kim D-H. Anti-inflammatory effects of black rice, cyanidin-3-O-β-D-glycoside, and its metabolites, cyanidin and protocatechuic acid. Int Immunopharmacol. 2010;10:959–966.
    1. Mink PJ, Scrafford CG, Barraj LM, Harnack L, Hong CP, Nettleton JA, et al. Flavonoid intake and cardiovascular disease mortality: a prospective study in postmenopausal women. Am J Clin Nutr. 2007;85:895–909.
    1. Miyazawa T, Nakagawa K, Kudo M, Muraishi K, Someya K. Direct intestinal absorption of red fruit anthocyanins, cyanidin-3-glucoside and cyanidin-3,5-diglucoside, into rats and humans. J Agric Food Chem. 1999;47:1083–1091.
    1. Mullen W, Rouanet J, Auger C, Teissèdre P, Caldwell S, Hartley R, et al. Bioavailability of [2-(14)C]quercetin-4′-glucoside in rats. J Agric Food Chem. 2008;56:12127–12137.
    1. Nardini M, Natella F, Scaccini C, Ghiselli A. Phenolic acids from beer are absorbed and extensively metabolized in humans. J Nutr Biochem. 2006;17:14–22.
    1. Nardini M, Forte M, Vrhovsek U, Mattivi F, Viola R, Scaccini C. White wine phenolics are absorbed and extensively metabolized in humans. J Agric Food Chem. 2009;57:2711–2718.
    1. Nizamutdinova IT, Kim YM, Chung JI, Shin SC, Jeong Y-K, Seo HG, et al. Anthocyanins from black soybean seed coats preferentially inhibit TNF-α-mediated induction of VCAM-1 over ICAM-1 through the regulation of GATAs and IRF-1. J Agric Food Chem. 2009;57:7324–7330.
    1. Nurmi T, Mursu J, Heinonen M, Nurmi A, Hiltunen R, Voutilainen S. Metabolism of berry anthocyanins to phenolic acids in humans. J Agric Food Chem. 2009;57:2274–2281.
    1. Pero RW. Health consequences of catabolic synthesis of hippuric acid in humans. Curr Clin Pharmacol. 2010;5:67.
    1. Rodriguez-Mateos A, Rendeiro C, Bergillos-Meca T, Tabatabaee S, George TW, Heiss C, et al. Intake and time dependence of blueberry flavonoid-induced improvements in vascular function: a randomized, controlled, double-blind, crossover intervention study with mechanistic insights into biological activity. Am J Clin Nutr. 2013;98:1179–1191.
    1. Stalmach A, Mullen W, Barron D, Uchida K, Yokota T, Cavin C, et al. Metabolite profiling of hydroxycinnamate derivatives in plasma and urine after the ingestion of coffee by humans: identification of biomarkers of coffee consumption. Drug Metab Disp. 2009;37:1749.
    1. Toromanović J, Kovač-Bešović E, Šapčanin A, Tahirović I, Rimpapa Z. Urinary hippuric acid after ingestion of edible fruits. Bosn J Basic Med Sci. 2008;8:38–43.
    1. Vane JR, Botting RM. The mechanism of action of aspirin. Thromb Res. 2003;110:255–258.
    1. Vitaglione P, Donnarumma G, Napolitano A, Galvano F, Gallo A, Scalfi L, et al. Protocatechuic acid is the major human metabolite of cyanidin-glucosides. J Nutr. 2007;137:2043–2048.
    1. Wang D, Wei X, Yan X, Jin T, Ling W. Protocatechuic acid, a metabolite of anthocyanins, inhibits monocyte adhesion and reduces atherosclerosis in apolipoprotein E-deficient mice. J Agric Food Chem. 2010;58:12722–12728.
    1. Williamson G, Clifford MN. Colonic metabolites of berry polyphenols: the missing link to biological activity? Br J Nutr. 2010;104(Suppl. 3):S48–S66.
    1. Wittemer SM, Ploch M, Windeck T, Müller SC, Drewelow B, Derendorf H, et al. Bioavailability and pharmacokinetics of caffeoylquinic acids and flavonoids after oral administration of Artichoke leaf extracts in humans. Phytomedicine. 2005;12:28–38.
    1. Woodward G, Kroon P, Cassidy A, Kay C. Anthocyanin stability and recovery: implications for the analysis of clinical and experimental samples. J Agric Food Chem. 2009;57:5271–5278.
    1. Woodward GM, Needs PW, Kay CD. Anthocyanin derived phenolic acids form glucuronides following simulated gastrointestinal digestion and microsomal glucuronidation. Mol Nutr Food Res. 2011;55:378–386.
    1. Xu J-W, Ikeda K, Yamori Y. Upregulation of endothelial nitric oxide synthase by cyanidin-3-glucoside, a typical anthocyanin pigment. Hypertension. 2004;44:217–222.
    1. Zhang Q, Botting NP, Kay C. A gram scale synthesis of a multi-13C-labelled anthocyanin,[6, 8, 10, 3′, 5′-13C5] cyanidin-3-glucoside, for use in oral tracer studies in humans. Chem Commun. 2011;47:10596–10598.
    1. Zhang Q, Saki Raheem K, Botting N, Slawin A, Kay C, O'Hagan D. Flavonoid metabolism: the synthesis of phenolic glucuronides and sulfates as candidate metabolites for bioactivity studies of dietary flavonoids. Tetrahedron. 2012;68:4194–4201.
    1. Zhang Y, Huo M, Zhou J, Xie S. PKSolver: an add-in program for pharmacokinetic and pharmacodynamic data analysis in Microsoft Excel. Comput Methods Programs Biomed. 2010;99:306–314.
    1. Zhu Y, Xia M, Yang Y, Liu F, Li Z, Hao Y, et al. Purified anthocyanin supplementation improves endothelial function via NO-cGMP activation in hypercholesterolemic individuals. Clin Chem. 2011;57:1524–1533.

Source: PubMed

Sponsorit ja yhteistyökumppanit

Sairaudet

Huumeiden interventiot

3
Tilaa